“Drug-Induced Liver Injury Clinical Consortia: a global research response for a worldwide health challenge”-Reference-Cited by-同舟云学术

“Drug-Induced Liver Injury Clinical Consortia: a global research response for a worldwide health challenge”

Published:2016-02-06 Issue:6 Volume:12 Page:589-593
ISSN:1742-5255
Container-title:Expert Opinion on Drug Metabolism & Toxicology
language:en
Short-container-title:Expert Opinion on Drug Metabolism & Toxicology

Author:

Andrade Raúl J.¹²,Ortega-Alonso Aida¹,Lucena María Isabel²³

Affiliation:

1. Unidad de Gestión Clínica de Enfermedades Digestivas, Instituto de Investigación Biomédica de Málaga (IBIMA), Hospital Universitario Virgen de la Victoria, Universidad de Málaga, Málaga, Spain

2. Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas (CIBERehd), Madrid, Spain

3. Servicio de Farmacología Clínica, Instituto de Investigación Biomédica de Málaga (IBIMA), Hospital Universitario Virgen de la Victoria, Universidad de Málaga, Málaga, Spain

Funder

Instituto de Salud Carlos III

EASL

Publisher

Informa Healthcare

Subject

Pharmacology,Toxicology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1517/17425255.2016.1141896

Reference15 articles.

1. Using controlled clinical trials to learn more about acute drug-induced liver injury

2. Drug-induced liver injury: Interactions between drug properties and host factors